Autifony Therapeutics
Developing medicine for CNS disorders
- B2B
About Autifony Therapeutics
Clinical stage biotech company developing new medicines for rare genetic CNS disorders through its innovative ion channel drug discovery platform
Key facts
- Industry
- Biotechnology Research
- Company size
- 11–50 employees
- Headquarters
- Stevenage, England, United Kingdom
- Founded
- 2011
- Revenue
- $6.8M – $53.8MTamtam estimate
- Website
- autifony.com
Autifony Therapeutics at a glance
Autifony Therapeutics is a B2B company in the Biotechnology Research industry, headquartered in Stevenage, England, United Kingdom.
Autifony Therapeutics was founded in 2011.
Autifony Therapeutics has 11–50 employees.
Autifony Therapeutics's revenue is $6.8M – $53.8M (Tamtam estimate).
Selling to companies like Autifony Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies